Though biologic medications have improved the treatment landscape by providing the solution to many unmet medical needs, biologics cost much more than small-molecule chemical medications. Biosimilars ...
Last week, FDA released a draft guidance, “Labeling for Biosimilar and Interchangeable Biosimilar Products” that—when finalized—will revise and replace its July 2018 final guidance, “Labeling for ...
Interchangeable biosimilar products would not be allowed to disclose or explain their interchangeability designations in their products’ labels under FDA’s new draft guidance. FDA justified its ...
When US regulators approved a new drug called Zarxio in March, it became the first FDA-approved biosimilar: a "copy" of a medication made from living things. Drugs derived from biological substances ...
The approval was based on a comprehensive review of scientific evidence that showed the 2 products were highly similar with no clinically meaningful differences. An interchangeable product is a ...
Biologics have revolutionized the management of immune-mediated inflammatory diseases (IMIDs). Biosimilars are biologics that exhibit no significant differences in safety or efficacy compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results